AXR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AXR is not a good immediate buy for a beginner long-term investor with $50,000-$100,000 who is unwilling to wait for a better entry. The company’s latest quarter showed very strong growth, but the technical picture is weak, there is no bullish proprietary signal, analyst sentiment has been downgraded to Hold, and there has been no recent insider or hedge fund accumulation. Based on the current data, I would hold off rather than buy now.
AXR is showing a short-term weakening trend. The MACD histogram is negative and expanding, which points to bearish momentum. RSI_6 at 31.3 is near oversold but not a clean buy signal by itself. Moving averages are converging, suggesting indecision rather than a confirmed uptrend. Price is sitting just above S1 support at 26.788, with pivot resistance at 27.685 and R1 at 28.583. The stock trend model also leans negative, implying downside bias over the next day, week, and month. Overall, the chart does not support an aggressive entry right now.
Latest quarter revenue rose 93.79% YoY, net income rose 338.91% YoY, EPS rose 346.15% YoY, and gross margin improved to 40.74%. These are strong operating improvements and show meaningful business momentum. There are no recent news items, so no fresh event-driven positives are currently evident.
Freedom Broker downgraded AXR to Hold from Buy, citing customer concentration in land development and a softening New Mexico housing market. The stock has already had a recent rally, which may have reduced near-term upside. Hedge funds and insiders are both neutral, with no significant buying trends. There is also no AI Stock Picker signal and no recent SwingMax signal. No recent news or congress trading data adds support.
In Q3 2026, AXR posted strong year-over-year growth: revenue increased to 14.57 million, net income increased to 3.15 million, EPS increased to 0.58, and gross margin expanded to 40.74%. This is a very strong latest-quarter operating result and indicates accelerating profitability. The main issue is not the financial snapshot, but whether that growth can be sustained given customer concentration and housing-market sensitivity.
Recent analyst action is negative-to-neutral: Freedom Broker downgraded Amrep to Hold from Buy on 2026-04-07, while keeping a $30 target after a prior $23 target. The rationale was recent stock strength, customer concentration risk, and softening New Mexico housing conditions. Wall Street’s pros view is that the company is showing strong earnings and margin growth; the cons view is that the business remains concentrated and cyclical, which limits confidence in further upside.
